Bowel (colorectal) cancer, Colon cancer, Rectal cancer, Secondary cancers
Results
Phase 2
This study looked at a drug called lonsurf. Lonsurf is a combination of 2 drugs, trifluridine and tipiracil.
It was for people who:
had bowel (colorectal) cancer that had spread to another part of the body and it wasn’t possible to remove these areas with an operation
weren’t fit enough to have intensive treatment
The study was open for people to join between 2016 and 2017. The team published the results in 2022.
Recruitment start: 29 April 2016
Recruitment end: 29 March 2017
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Saunders
Experimental Cancer Medicine Centre (ECMC)
Servier Research and Development Ltd
Last reviewed: 27 Nov 2025
CRUK internal database number: 14091
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
